(Bloomberg) — Clover Health, an insurance startup using data science for preventative health care, has become Silicon Valley's newest, and a rather reluctant, unicorn.
Alphabet Inc.'s venture arm GV and other investors have put $130 million into the San Francisco-based company, valuing it at $1.2 billion, according to people familiar with the matter. Startups worth more than $1 billion on paper are known as unicorns. The funding round closed Wednesday.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
